Anicura KBH Dyrehospital Komplementarselskab ApS: Financial statements 2012
CVR: 33250258
Anicura KBH Dyrehospital Komplementarselskab ApS (CVR 33250258) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 93,750 and a net result of DKK 74,924. Equity amounted to DKK 294,444. The solvency ratio was 96.3%.
- Gross Profit
- 93,750 kr.
- Profit/Loss
- 74,924 kr.
- Equity
- 294,444 kr.
- Total Assets
- 305,694 kr.
How creditworthy is Anicura KBH Dyrehospital Komplementarselskab ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of December 3, 2012, Martin Bøje Vassing has joined the board of directors of Anicura KBH Dyrehospital Komplementarselskab ApS.
As of December 3, 2012, Jens Ole Gjerluf Eslau has joined the board of directors of Anicura KBH Dyrehospital Komplementarselskab ApS.
As of December 3, 2012, Wilfried Hugo Heinrich Goecke has left the board of directors of Anicura KBH Dyrehospital Komplementarselskab ApS.
As of December 3, 2012, Ingeborg Mølbak has left the board of directors of Anicura KBH Dyrehospital Komplementarselskab ApS.
As of December 3, 2012, Olav Frederik Toftdahl Bagge has left the board of directors of Anicura KBH Dyrehospital Komplementarselskab ApS.
As of December 3, 2012, Nils Brendorp has left the board of directors of Anicura KBH Dyrehospital Komplementarselskab ApS.
As of December 3, 2012, Jens Ole Gjerluf Eslau is registered as director of Anicura KBH Dyrehospital Komplementarselskab ApS.
As of December 3, 2012, Hanne Werner is registered as chairman of Anicura KBH Dyrehospital Komplementarselskab ApS.
As of December 3, 2012, Wilfried Hugo Heinrich Goecke has stepped down as director of Anicura KBH Dyrehospital Komplementarselskab ApS.
About Anicura KBH Dyrehospital Komplementarselskab ApS
Anicura KBH Dyrehospital Komplementarselskab ApS was a Danish company of the type Anpartsselskab based in Herlev, founded in 2010 and dissolved in 2023. The company was registered under the industry Dyrlæger. In 2022, the company reported a gross profit of DKK 110,039 and a net result of DKK 86,969 compared with DKK 86,474 the year before. Equity amounted to DKK 432,561.
